•  
  •  
  •  
  •  

2026-05-27 04:34:47

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Marico enters the hair cleansing segment with Parachute Advansed Protein Shampoo
  • Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT
  • ITCONS E-Solutions Ltd receives new contract worth Rs. 3.36 crore
  • CIL allays supply worries as coal use goes up
  • Denta Water and Infra Solutions Reports Strong FY26 Performance

Keywords Selected:  EU

Research

  • Tata Motors CV Listing: A Strong Value Unlock Story
  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Axis Securities' Monthly Auto Volume Update - July 2024
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • CRISIL Ratings: Slowing US, EU to chip 6-8% away from handicraft sales this fiscal
  • 10,000+ women entrepreneurs have dispensed over ₹900 crores of financial services in the last financial year: PayNearby Study
  • Company Update - P&G Health - ICICI Direct
  • ICRA's sample set of Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

Market Commentary

  • Mr. Asheesh Chanda, Founder & CEO, Kristal.AI on depreciation of Euro against USD
  • Finance Minister announces reduction of Central Excise Duty on Petrol, Diesel
  • India must regulate cryptocurrencies in consumer interest and to promote innovation: Esya Centre, ORF report

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Leading Decorative Wall Panel & Premium Laminates Brand Euro Pratik files DRHP for Rs 730 crore IPO
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT
  • Fredun Pharmaceuticals Announces 2:1 Bonus Issue, Signaling Strong Growth Confidence
  • Fredun Pharmaceuticals Delivers Robust FY26 Performance
  • Gujarat Inject Kerala Ltd delivers robust FY26 performance, Net Profit rises 78% YoY
  • Classification of Unit-I of Eugia Pharma Specialities Ltd, Shameerpet as OAI
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • Lupin receives China Approval for Oseltamivir Phosphate Oral Suspension
  • Venus Remedies receives Saudi FDA approval for Plerixafor - its first Marketing Authorization for the specialty oncology therapy globally
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Levothyroxine Sodium Tablets USP
  • Nucleus Software Announces Strong FY 2025-26 Performance
  • Eris delivers 11% yoy growth in Domestic Formulations with 37% EBIDTA margin in FY26
  • Zydus Lifesciences Limited Financial Performance for Q4 & Full Year FY26
  • Senores Pharmaceuticals Ltd posts consolidated PAT of Rs. 36.67 crores in Q4FY26
  • Akums Drugs and Pharmaceuticals Ltd consolidated Q4 FY2025-26 profit at Rs. 87.40 crores
  • Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
  • GlaxoSmithKline Pharmaceuticals Ltd announces Q4, FY26 results
  • Smruthi Organics Ltd recommends dividend of Rs. 1.5
  • Cipla Ltd recommends final dividend of Rs. 13
  • HPCL recommends final dividend of Rs. 19.25
  • GlaxoSmithKline Pharmaceuticals Ltd consolidated Q4FY26 PAT at Rs. 277.86 crores
  • Hindustan Petroleum Corporation Ltd Q4 FY2026 consolidated profit climbs to Rs. 6065.26 crores
  • Pfizer Ltd recommends final dividend of Rs. 75
  • Albert David Limited recommends final dividend of Rs. 5
  • Neuland Laboratories Ltd recommends final dividend of Rs. 34

Industry News

  • Healthcare diagnostics startup Neuranics Raises $700K US Funding in Seed Round Led by Inflection Point Ventures
  • Wundrsight raises USD 400K in a Seed Round led by Inflection Point Ventures
  • Neo Raises INR 400 Crore in Latest Funding Round Led by MUFG and Euclidean Capital
  • NSE's consolidated Q1 FY25 operating revenue up by 51% YoY at Rs.4,510 crores
  • Agoda: More Europeans Searching for Travel to Asia This Summer
  • HCL Group and UpLink Open Applications for its Third Global Aquapreneur Innovation Challenge
  • Honeywell Launches World's First 100% Hydrogen-Capable Gas Meter
  • MakeMyTrip launches a gamut of customizable holiday packages for Europe
  • FLAME University launches an interdisciplinary Bachelor of Design program
  • The UNLEASH Global Innovation Lab brings together youth to create disruptive solutions that fast-track SDG progress
  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India
  • MakeMyTrip joins hands with Climes to encourage travellers to neutralize their flight emissions

Latest Post

  • Marico enters the hair cleansing segment with Parachute Advansed Protein Shampoo
  • Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT
  • ITCONS E-Solutions Ltd receives new contract worth Rs. 3.36 crore
  • CIL allays supply worries as coal use goes up
  • Denta Water and Infra Solutions Reports Strong FY26 Performance


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025